Holen Sie sich die Stockscreener-App
0.685
1.26%
-0.00395
Schlusskurs vom Vortag:
$0.6889
Offen:
$0.695
24-Stunden-Volumen:
249.94K
Relative Volume:
0.89
Marktkapitalisierung:
$46.89M
Einnahmen:
$2.98M
Nettoeinkommen (Verlust:
$-15.29M
KGV:
-2.6829
EPS:
-0.2553
Netto-Cashflow:
$-14.25M
1W Leistung:
+7.97%
1M Leistung:
+19.33%
6M Leistung:
-30.98%
1J Leistung:
-50.71%
1-Tages-Spanne:
$0.651
$0.6989
1-Wochen-Bereich:
$0.5951
$0.71
52-Wochen-Spanne:
$0.5401
$1.53
Icecure Medical Ltd Stock (ICCM) Company Profile
Firmenname
Icecure Medical Ltd
Sektor
Branche
Telefon
-
Adresse
-
Compare ICCM vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ICCM
Icecure Medical Ltd
|
0.68 | 47.51M | 2.98M | -15.29M | -14.25M | -0.2553 |
|
ABT
Abbott Laboratories
|
108.04 | 187.91B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
337.19 | 129.05B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
87.08 | 112.19B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
69.02 | 101.72B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
81.77 | 49.14B | 6.07B | 1.06B | 1.34B | 1.8063 |
Icecure Medical Ltd Aktie (ICCM) Neueste Nachrichten
Icecure Medical Ltd expected to post a loss of 4 cents a shareEarnings Preview - TradingView
U.S. FDA Approves IceCure's Post-Marketing "ChoICE" Study for ProSense Cryoablation in the Local Treatment of Low-Risk Breast Cancer - Finviz
FDA Greenlights IceCure’s ProSense® Study for Breast Cancer - Zenopa
IceCure Wins FDA Nod for U.S. Post-Marketing ChoICE Study of ProSense Cryoablation in Low-Risk Breast Cancer - TipRanks
FDA clears IceCure (Nasdaq: ICCM) ProSense post-market ChoICE study in breast cancer - Stock Titan
IceCure Medical (ICCM) Receives FDA Approval for Post-Market Stu - GuruFocus
U.S. FDA Approves IceCure's Post-Marketing "ChoICE" Study for ProSense® Cryoablation in the Local Treatment of Low-Risk Breast Cancer - PR Newswire
Movement Recap: Is IceCure Medical Ltd showing insider buyingRecession Risk & Fast Exit Strategy with Risk Control - baoquankhu1.vn
IceCure Medical to Report 2025 Full Year Financial and Operating Results on March 17, 2026 - Finviz
IceCure Medical to Report 2025 Full Year Financial and Operating Results on March 17, 2026 - Benzinga
IceCure Gains Key ASBrS Backing for ProSense Cryoablation in Low-Risk Breast Cancer - TipRanks
American Society of Breast Surgeons (ASBrS) Resource Guide Update Recommends Cryoablation for Low-Risk Breast Cancer - The Malaysian Reserve
Meme Stocks: Can IceCure Medical Ltd outperform under higher oil pricesTrade Performance Summary & Weekly Breakout Opportunity Watchlist - baoquankhu1.vn
Bank Watch: Is IceCure Medical Ltd a strong candidate for buy and holdJuly 2025 WrapUp & Smart Swing Trading Techniques - baoquankhu1.vn
Sell Signal: Is IceCure Medical Ltd a stock for growth or value investors2025 Market WrapUp & AI Powered Market Trend Analysis - baoquankhu1.vn
Does IceCure Medical Ltd outperform in volatile markets2025 Key Highlights & Smart Swing Trading Techniques - baoquankhu1.vn
IceCure Medical Highlights New PLOS One Data Showing ProSense Cryoablation Effective for Breast Fibroadenomas - TipRanks
Independent ProSense study on breast tumors for IceCure (ICCM) - Stock Titan
IceCure Medical Reports Independent Study Published in PLOS One Demonstrating ProSense® Cryoablation Safe and Effective in Treatment of Breast Fibroadenomas - Barchart.com
ICCM Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
ICCM Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
ICCM Should I Buy - Intellectia AI
ICCM Completes Key 5-Year Follow-Up in Kidney Cancer Clinical Tr - GuruFocus
IceCure Medical Completes Five-Year Follow Up in ICESECRET Kidney Cancer Cryoablation Study - TipRanks
S P Trends: Is IceCure Medical Ltd subject to activist investor interest2025 Volatility Report & Risk Managed Trade Strategies - baoquankhu1.vn
IceCure Medical Successfully Completes 5-Year Patient Follow Up in ICESECRET Kidney Cancer Cryoablation Study: Final Analysis Expected in Second Quarter of 2026 - PR Newswire
IceCure Medical Successfully Completes 5-Year Patient Follow Up - GuruFocus
Is IceCure Medical Ltd stock a good dividend stock2025 Technical Overview & Low Risk Profit Maximizing Plans - mfd.ru
IceCure Announces Thomas Hospital of Infirmary Health Installs ProSense, Becomes First Hospital in Alabama to Offer Breast Cancer Cryoablation - marketscreener.com
Is IceCure Medical Ltd stock overvalued by current metricsWeekly Investment Recap & Technical Pattern Based Buy Signals - mfd.ru
IceCure Medical Ltd. Announces Thomas Hospital of Infirmary Health Installs ProSense®?, Becomes First Hospital in Alabama to Offer Breast Cancer Cryoablation - marketscreener.com
IceCure Announces Thomas Hospital of Infirmary Health Installs P - GuruFocus
IceCure Announces Thomas Hospital of Infirmary Health Installs ProSense®, Becomes First Hospital in Alabama to Offer Breast Cancer Cryoablation - PR Newswire
Aug Weekly: Does IceCure Medical Ltd outperform in volatile marketsEarnings Risk Report & Reliable Volume Spike Trade Alerts - baoquankhu1.vn
Stock Report: Is IceCure Medical Ltd a strong candidate for buy and hold2025 Retail Activity & Free Community Consensus Stock Picks - baoquankhu1.vn
Is IceCure Medical Ltd subject to activist investor interestWeekly Investment Summary & Stepwise Trade Signal Guides - mfd.ru
Stock Market Recap: How does Universal Corporation compare to its peersInsider Buying & Weekly Momentum Stock Picks - baoquankhu1.vn
What’s the MACD signal for IceCure Medical LtdOptions Play & AI Forecasted Entry/Exit Points - mfd.ru
IceCure Announces Shero Imaging is First to Offer Breast Cancer Cryoablation Procedures in Missouri with ProSense - Finviz
IceCure Medical Ltd. Announces Shero Imaging is First to Offer Breast Cancer Cryoablation Procedures in Missouri with ProSense - marketscreener.com
IceCure Announces Shero Imaging is First to Offer Breast Cancer Cryoablation Procedures in Missouri with ProSense® - GuruFocus
Why IceCure Medical Ltd stock is popular among millennialsQuarterly Investment Review & Free High Return Stock Watch Alerts - mfd.ru
IceCure CFO Ronen Tsimerman to depart - MSN
How IceCure Medical Ltd stock compares to industry benchmarksDividend Hike & Free Technical Confirmation Trade Alerts - mfd.ru
IceCure Announces Planned Departure of CFO Following Nine Years of Service and Key Milestones Achieved - Sahm
IceCure Medical CFO to Step Down After Nearly Decade of Service as Succession Search Advances - The Globe and Mail
ICCM: IceCure Medical's CFO Announces Departure - GuruFocus
IceCure Medical (NASDAQ: ICCM) CFO plans departure after 9 years - Stock Titan
Aug Volume: Can IceCure Medical Ltd be recession proofLong Setup & AI Enhanced Trading Signals - baoquankhu1.vn
Is IceCure Medical Ltd stock heavily shortedJuly 2025 Market Mood & Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
What is IceCure Medical Ltds 5 year growth outlook2025 Risk Factors & Accurate Technical Buy Alerts - baoquankhu1.vn
Finanzdaten der Icecure Medical Ltd-Aktie (ICCM)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.70%
0.75%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):